Table 2. . Summary of key whole brain radiotherapy studies.
Study | No. of patients (% melanoma) | Treatment (no.) | Local control (%) | Median overall survival (months) | Ref. |
---|---|---|---|---|---|
Brown et al. | 41 (56) | SRS alone 18 Gy (15) SRS + WBRT 30–50Gy/10–25 fx |
SRS alone: 85†SRS + WBRT: 100†‡ | 14.2 | [24] |
Hauswald et al. | 87 (100) | WBRT 30 Gy/10 fx (56) 40 Gy/20 fx (31) |
NR | All: 3.5 30 Gy: 3.1 40 Gy: 5.6‡ |
[28] |
Rades et al. | 51 (100) | WBRT 30 Gy/10 fx (33) 40 Gy/20 fx (11) 45 Gy/15 fx (7) |
30 Gy: 23† 40–45 Gy: 50†,‡ |
30 Gy: 27%† 40–45 Gy: 50%†‡ |
[29] |
Ellerhorst et al. | 87 (100) | WBRT 15–50 Gy/5–25 fx |
NR | 4.75 | [30] |
Dyer et al. | 147 (100) | SRS + Up-front WBRT (39) + Salvage WBRT (33) |
NR | 7.3 | [31] |
†At 6 months;
‡statistically significant difference.
fx: Fractions; NR: Not reported; SRS: Stereotactic radiosurgery; WBRT: Whole brain radiotherapy.